Olga Mucha

675 total citations
24 papers, 490 citations indexed

About

Olga Mucha is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Olga Mucha has authored 24 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Olga Mucha's work include Muscle Physiology and Disorders (11 papers), Adipose Tissue and Metabolism (7 papers) and Heme Oxygenase-1 and Carbon Monoxide (7 papers). Olga Mucha is often cited by papers focused on Muscle Physiology and Disorders (11 papers), Adipose Tissue and Metabolism (7 papers) and Heme Oxygenase-1 and Carbon Monoxide (7 papers). Olga Mucha collaborates with scholars based in Poland, United States and Italy. Olga Mucha's co-authors include Paulina Podkalicka, Józef Dulak, Agnieszka Łoboda, Alicja Józkowicz, Jacek Stępniewski, Mateusz Sobczak, Anna Stachurska, Neli Kachamakova‐Trojanowska, Magdalena Kozakowska and Karolina Bukowska-Straková and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Olga Mucha

24 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Mucha Poland 14 377 86 73 65 57 24 490
Paulina Podkalicka Poland 16 465 1.2× 105 1.2× 101 1.4× 71 1.1× 73 1.3× 26 596
Yanlian Xiong China 13 214 0.6× 97 1.1× 56 0.8× 26 0.4× 63 1.1× 31 478
Yingmin Zhang China 11 346 0.9× 60 0.7× 58 0.8× 36 0.6× 79 1.4× 30 562
Minxiang Lei China 14 303 0.8× 84 1.0× 77 1.1× 49 0.8× 89 1.6× 28 610
Libin Ni China 14 312 0.8× 51 0.6× 95 1.3× 22 0.3× 34 0.6× 21 618
Sonia Bergante Italy 13 212 0.6× 80 0.9× 43 0.6× 41 0.6× 105 1.8× 17 537
Xiao‐Bing Cui China 17 282 0.7× 103 1.2× 83 1.1× 38 0.6× 101 1.8× 26 698
Joanna Brzeszczyńska United Kingdom 14 321 0.9× 132 1.5× 28 0.4× 51 0.8× 64 1.1× 29 576
Fang Du China 13 288 0.8× 122 1.4× 85 1.2× 32 0.5× 37 0.6× 25 557
Gholamreza Taheripak Iran 12 306 0.8× 115 1.3× 110 1.5× 23 0.4× 41 0.7× 21 522

Countries citing papers authored by Olga Mucha

Since Specialization
Citations

This map shows the geographic impact of Olga Mucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Mucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Mucha more than expected).

Fields of papers citing papers by Olga Mucha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Mucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Mucha. The network helps show where Olga Mucha may publish in the future.

Co-authorship network of co-authors of Olga Mucha

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Mucha. A scholar is included among the top collaborators of Olga Mucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Mucha. Olga Mucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mucha, Olga, et al.. (2025). GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Attenuates Skeletal Muscle Abnormalities in a Murine Model of Duchenne Muscular Dystrophy. Antioxidants and Redox Signaling. 43(1-3). 115–137. 1 indexed citations
2.
Pośpiech, Ewelina, Mateusz Wilamowski, Olga Mucha, et al.. (2024). MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 17(6). 887–906. 8 indexed citations
3.
Mucha, Olga, Paulina Podkalicka, Bianka Świderska, et al.. (2023). Proteome Profiling of the Dystrophic mdx Mice Diaphragm. Biomolecules. 13(11). 1648–1648. 7 indexed citations
5.
Mucha, Olga, et al.. (2023). Sodium hydrosulfide moderately alleviates the hallmark symptoms of Duchenne muscular dystrophy in mdx mice. European Journal of Pharmacology. 955. 175928–175928. 6 indexed citations
6.
Podkalicka, Paulina, Olga Mucha, Krzysztof Szade, et al.. (2022). miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Scientific Reports. 12(1). 3945–3945. 14 indexed citations
7.
Mucha, Olga, et al.. (2021). Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy. Skeletal Muscle. 11(1). 18 indexed citations
8.
Podkalicka, Paulina, Olga Mucha, Magdalena Kozakowska, et al.. (2020). Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight. 5(11). 27 indexed citations
9.
Podkalicka, Paulina, Olga Mucha, Anna Biela, et al.. (2020). Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes. Biomolecules. 10(1). 143–143. 15 indexed citations
10.
Krist, Bart, Paulina Podkalicka, Olga Mucha, et al.. (2019). miR-378a influences vascularization in skeletal muscles. Cardiovascular Research. 116(7). 1386–1397. 26 indexed citations
11.
Podkalicka, Paulina, Olga Mucha, Józef Dulak, & Agnieszka Łoboda. (2019). Targeting angiogenesis in Duchenne muscular dystrophy. Cellular and Molecular Life Sciences. 76(8). 1507–1528. 42 indexed citations
12.
Mucha, Olga, Paulina Podkalicka, Alicja Józkowicz, et al.. (2019). miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skeletal Muscle. 9(1). 22–22. 25 indexed citations
13.
Lipiński, Paweł, Rafał R. Starzyński, Witold N. Nowak, et al.. (2019). Role of the kidneys in the redistribution of heme-derived iron during neonatal hemolysis in mice. Scientific Reports. 9(1). 11102–11102. 11 indexed citations
14.
Podkalicka, Paulina, Olga Mucha, Alicja Józkowicz, Józef Dulak, & Agnieszka Łoboda. (2018). Heme oxygenase inhibition in cancers: possible tools and targets. Współczesna Onkologia. 2018(1). 23–32. 75 indexed citations
15.
Pietraszek‐Gremplewicz, Katarzyna, Magdalena Kozakowska, Maciej Cieśla, et al.. (2018). Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Antioxidants and Redox Signaling. 29(2). 128–148. 40 indexed citations
16.
Łoboda, Agnieszka, Olga Mucha, Paulina Podkalicka, et al.. (2018). Kidney injury by cyclosporine A is aggravated in heme oxygenase-1 deficient mice and involves regulation of microRNAs. Acta Biochimica Polonica. 65(4). 613–620. 11 indexed citations
17.
Mucha, Olga, Paulina Podkalicka, Anna Biela, et al.. (2018). Pharmacological versus genetic inhibition of heme oxygenase-1 – the comparison of metalloporphyrins, shRNA and CRISPR/Cas9 system. Acta Biochimica Polonica. 65(2). 277–286. 22 indexed citations
18.
Łoboda, Agnieszka, Anna Stachurska, Mateusz Sobczak, et al.. (2017). Nrf2 deficiency exacerbates ochratoxin A-induced toxicity in vitro and in vivo. Toxicology. 389. 42–52. 43 indexed citations
19.
Łoboda, Agnieszka, Anna Stachurska, Paulina Podkalicka, et al.. (2017). Effect of heme oxygenase-1 on ochratoxin A-induced nephrotoxicity in mice. The International Journal of Biochemistry & Cell Biology. 84. 46–57. 26 indexed citations
20.
Łoboda, Agnieszka, Szymon Czauderna, Olga Mucha, et al.. (2016). Comparison of shRNA and CRISPR/Cas9 in heme oxygenase-1 targeting efficiency. New Biotechnology. 33. S170–S170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026